Last checked at Today 09:39
LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News1
GSK Share
Chat
GSK Share
Trades6,772
GSK
Live RNS2
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,773.50
Bid:
1,772.00
Ask:
1,772.50
Change:
12.50 (0.71%)
Spread:
0.50 (0.028%)
Open:
1,770.00
High:
1,776.00
Low:
1,766.00
Prev. Close:
1,761.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.London pre-open: All eyes on the OPEC meeting, stocks inch higher
Thu, 27th Nov 2014 07:32
US markets might be closed together for Thanksgiving but those hoping for a quiet day could be disappointed with the Organization of Petroleum Exporting Countries (OPEC) set for a pivotal meeting in Vienna.City sources predict the FTSE 100 will open around eight points higher than yesterday's close of 6,729.17.The Brent crude price tumbled below $78 a barrel on the eve of the OPEC meeting after Saudi Arabia and the United Arab Emirates hinted that they had no intention of cutting production levels to prop up prices."Whether or not it will cut its output target to curb the downward pressure on oil prices looks to be a close call," said analysts at Danske Bank.In other news, industrial profits in China slumped in October, according to the National Bureau of Statistics, as weak demand, rising costs of labour and falling product prices took their toll on companies' bottom lines.Profits of Chinese industrial businesses fell by 2.1% over the year before to 575.47bn yuan (£59.4bn). This compared with 0.4% growth in September and was the worst annual decline registered in two years.Stocks to watchGlaxosmithkline said it is on track to complete its complex three-way £11bn deal with Swiss pharmaceutical peer Novartis next year after US regulators approved the first two parts of the transaction. The US Federal Trade Commission has now given the green light for GSK's acquisition of Novartis' vaccines business (which excludes its influenza vaccines) as well as the proposed creation of the consumer-healthcare tie-up.Stagecoach Group's 90%-owned joint venture with Virgin Rail has won the contract to run the new InterCity East Coast franchise for eight years from March 2015. The franchise contract requires the pair to commit to paying the government £2.3bn in premium payments, which the companies said would be a higher return to the taxpayer than under the current arrangements.Rigid plastic packaging supplier RPC Group said its revenue grew in the first half of 2014, courtesy of business acquisitions and satisfying progress in its existing programmes. Revenue in the six months to September rose 12% to £588.9m, with profit before tax increasing from £30.1m to £34.9m, while net profit went from £6m to £20.2m.Insurance and investment services group Legal & General has won a £2.5bn bulk annuity contract with the UK pension scheme of US car-parts group TRW Automotive.
More News
7 May 2024 09:51
LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:
Read more2 May 2024 19:57
GSK knew about Zantac cancer risk, attorneys tell jury in first trial
May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.
Read more2 May 2024 09:48
LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:
Read more1 May 2024 19:39
Bird flu testing shows more dairy products are safe, US FDA says
CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.
Read more1 May 2024 17:31
UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh
FTSE 100 down 0.3%, FTSE 250 off 0.2%
*Read more1 May 2024 16:56
LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision
(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.
Read more1 May 2024 16:42
London close: Stocks fall ahead of US Fed decision
(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.
Read more1 May 2024 11:55
LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage
(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.
Read more1 May 2024 10:54
GSK raises profit outlook on strong vaccine, HIV drug sales
FY profit forecast raised to 8-10%
*Read more1 May 2024 08:57
LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed
(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.
Read more1 May 2024 08:50
TOP NEWS: GSK expects momentum to continue after strong first quarter
(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.
Read more1 May 2024 07:46
LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast
(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.
Read more1 May 2024 07:36
GSK lifts annual guidance on strong virus treatment sales
(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.
Read more30 Apr 2024 23:46
First trial over Zantac cancer claims set to begin in Chicago
April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.
Read more